The Content and Comprehensiveness of Hepatitis C Education in Methadone Maintenance and Drug-Free Treatment Units

Journal of Urban Health

Volumn 81, Issue 1, 2004, Pages 38-47

  Strauss, Shiela M ^a   Astone, Janetta M ^a   Hagan, Holly ^a   Des Jarlais, Don C ^b,c  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c E R Found Chem Dependency Inst

Author keywords

Drug treatment programs; Education; Hepatitis C

Indexed keywords

ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DRUG DEPENDENCE TREATMENT; DRUG FREE TREATMENT PROGRAM; EDUCATION PROGRAM; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH EDUCATION; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INJECTION; MAJOR CLINICAL STUDY; METHADONE TREATMENT; PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION;

ANALGESICS, OPIOID; HEALTH CARE SURVEYS; HEALTH EDUCATION; HEPATITIS C; HUMANS; METHADONE; PROGRAM EVALUATION; RISK REDUCTION BEHAVIOR; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 2442509837     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jth086     Document Type: Article

References (33)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
2. Seeff LB. Natural history of hepatitis C. Am J Med. 1999;107(6B):10S-15S.
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep. 1998;47:1-39.
4. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology. 1997;26:521-526.
5. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1991;12:671-675.
6. Simonetti RG, Camma C, Fiorello F. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: a case-control study. Ann Intern Med. 1992;116:97-102.
7. Yu MC, Tong MJ, Corsaget P. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst. 1990;82:1038-1041.
8. Hagan H, Thiede H, Weiss HS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42-46.
9. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine. 1995;74:212-220.
10. Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. Br Med J. 1999;319:290-291.
11. Dhopesh VP, Taylor KR, Burke WM. Survey of hepatitis B and C in an addiction treatment unit. Am J Drug Alcohol Abuse. 2000;26:703-707.
12. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 2002;97:1289-1294.
13. Stein MD, Maksad J, Clarke, J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend. 2001;61:211-215.
14. Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis. 2001;20:15-25.
15. Tortu S, Neaigus A, McMahon J, Hagan D. Hepatitis C among non-injecting drug users: a report. Subst Use Misuse. 2001;36:523-534.
16. Bae JP. Assessing the need, use, and developments in mental health/substance abuse care. Health Care Financ Rev. 1997;18:1-4.
17. Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999;34:727-746.
18. Contoreggi C, Rexroad VE, Lange WR. Current management of infectious complications in the injecting drug user. J Subst Abuse Treat. 1998;15:95-106.
19. Clapp JD. Organizational factors related to AIDS/HIV education in outpatient substance abuse treatment units. J Health Soc Policy. 1998;9:1-13.
20. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(suppl 1):97-106.
21. D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. J Health Soc Behav. 1999;40:175-192.
22. Friedmann PD, Alexander JA, D'Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. J Subst Abuse Treat. 1999;16:71-80.
23. Grella CE, Etheridge RM, Joshi V, Anglin MD. Delivery of HIV risk-reduction services in drug treatment programs. J Subst Abuse Treat. 2000;19:229-237.
24. Polinsky ML, Hser Y-I, Anglin MD, Maglione MA. Drug-user treatment programs in a large metropolitan area. Subst Use Misuse. 1998;33:1735-1761.
25. Astone J, Strauss SM, Vassilev ZP, Des Jarlais DC. Provision of hepatitis C education in a nationwide sample of drug treatment programs. J Drug Educ. 2003;33:107-117.
26. Strauss SM, Astone J, Vassilev ZP, Des Jarlais DC, Hagan H. Gaps in the drug-free and methadone maintenance treatment program response to hepatitis C. J Subst Abuse Treat. 2003;24:291-297.
27. Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002;22:55-62.
28. D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. J Health Soc Behav. 1999;40:175-192.
29. D'Aunno TA, Vaughn TE. An organizational analysis of service patterns in outpatient drug abuse treatment units. J Subst Abuse. 1995;7:27-42.
30. Cronbach LJ. Coefficient α and the internal structure of tests. Psychometrika. 1951;16:297-334.
31. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286-290.
32. Wong V, Wreghitt TG, Alexander GJM. A prospective study of hepatitis B vaccination in patients with chronic hepatitis C. Br Med J. 1996;312:1336-1337.
33. Strauss SM, Astone J, Des Jarlais DC, Hagan H. The relationship between HIV testing and HCV antibody testing in methadone maintenance and drug-free treatment programs. Poster presented at: Sixty-fifth Annual Meeting of the College on Problems of Drug Dependence; June 16, 2003; Bal Harbour, FL.